LifeNet Health’s LifeSciences Division features biologically precise research solutions at Society of Toxicology – TOX EXPO
Visit booth 1661 to learn about biologically relevant human tissue, cells and services for research and scientific investigation

This National Donor Day, Share Your Wish with Your Family to Help Save Lives

Rony Thomas, President and CEO, LifeNet Health

Jordan Gill was a hero. In 2015, he died in an ATV accident. He was just 33 years old, but he made a decision during his lifetime that ensured something beautiful arose from such a tragedy. He chose to be an organ and tissue donor.

Orlando, Fla. — Oct. 25, 2017 — LifeNet Health has introduced its latest allograft bone-healing solution, the PliaFX^® Strip, offering optimized handling and effective performance in a convenient, preformed shape. It is the first in a new family of grafts composed of 100 percent cortical bone fibers, created using an exclusive, patented processing technology.

Pensacola, Fla. – More than 5,700 Floridians are waiting for life-saving organ transplants, and thousands of others this year will need tissue and cornea transplants that can improve health and restore sight. 

SAN DIEGO (June 19, 2017) — The recently formed LifeSciences Division of LifeNet Health is exhibiting at this week's BIO International Convention in San Diego (Booth 1650), where it will be introducing its proprietary drug discovery and pre-clinical research solutions.

LifeNet Health continues strategic growth with
Austrian tissue bank acquisition

European headquarters in Vienna will serve as training, distribution center

Virginia Beach, Va. — Feb. 13, 2017 — LifeNet Health, a leading, non-profit regenerative medicine company, has completed an all-equity acquisition of Austrian tissue bank AlloTiss Gemeinnützige Gewebebank GmbH.

Renton, Wash. — Jan. 10, 2017 — LifeNet Health, the only full-service, non-profit tissue bank operating in the Pacific Northwest has begun production of ViviGen^® Cellular Bone Matrix in its Northwest headquarters in Renton, Wash. ViviGen, an innovative cellular allograft developed by LifeNet Health, incorporates viable bone cells that support the healing process.

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health is expanding its cell-based research and processing capacity with the opening of a facility in North Carolina’s Research Triangle Park (RTP), near Durham. It will be an extension of its flagship research center, the LifeNet Health Institute of Regenerative Medicine, located at the company’s headquarters in Virginia Beach, Va.

Virginia Beach, Va. — Nov. 2, 2016 — LifeNet Health has acquired the assets of Alabama-based biotechnology company Vivo Biosciences, Inc., as part of the organization’s growing emphasis on applying cell-based innovations to the process of pharmaceutical discovery and personalized medicine.

LifeNet Health, a leading provider of allograft surgical solutions, has been honored as a 2016 winner of Premier Inc.’s Supplier Horizon Award.

One of 12 organizations — chosen from among 253 suppliers — to receive the award this year, LifeNet Health was recognized for its support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence, and commitment to lower costs.